Narayana Hrudayalaya, listed as NSE:NH, has reported robust financial results for the second quarter of 2024, showcasing impressive growth across key financial metrics.
Revenue: ₹13.2 billion, marking a substantial 16% increase from the same period in 2023.
Net Income: ₹2.27 billion, reflecting a notable 34% rise from the second quarter of 2023.
Profit Margin: 17%, a commendable increase from the 15% reported in the second quarter of 2023. The rise in margin is attributed to the higher revenue generated during this period.
Earnings Per Share (EPS): ₹11.16, a significant increase from ₹8.31 in the second quarter of 2023.
The financial performance of Narayana Hrudayalaya surpassed expectations, with revenue surpassing analyst estimates by 2.3%. Earnings per share (EPS) outperformed analyst expectations by an impressive 51%.
Looking ahead, Narayana Hrudayalaya anticipates a robust growth trajectory, with a forecasted average annual revenue growth of 11% over the next three years. This growth outlook positions the company favorably, especially when compared to the broader Healthcare industry in India, which is forecasted to grow at a rate of 15%.
Despite the challenges faced by the Indian Healthcare industry, Narayana Hrudayalaya’s share price has demonstrated resilience, remaining relatively unchanged from the previous week. As of 11:02 am, the shares were trading 4.37% higher at ₹1,132.00.
